Ventas (NYSE:VTR) Issues FY 2026 Earnings Guidance

Ventas (NYSE:VTRGet Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 3.850-3.900 for the period, compared to the consensus earnings per share estimate of 3.880. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

VTR has been the subject of several research analyst reports. Cantor Fitzgerald boosted their price objective on Ventas from $97.00 to $102.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $100.00 price objective on shares of Ventas in a research report on Tuesday, June 16th. Mizuho raised their price objective on shares of Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Raymond James Financial assumed coverage on shares of Ventas in a research note on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 target price for the company. Finally, Barclays began coverage on Ventas in a report on Tuesday, July 7th. They issued an “equal weight” rating and a $99.00 price target on the stock. Fifteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, Ventas has an average rating of “Moderate Buy” and a consensus price target of $97.56.

Get Our Latest Analysis on Ventas

Ventas Stock Up 1.5%

NYSE VTR traded up $1.36 during trading hours on Wednesday, hitting $92.21. 968,519 shares of the company traded hands, compared to its average volume of 3,676,723. The business’s 50-day moving average is $89.10 and its 200-day moving average is $85.85. Ventas has a twelve month low of $66.38 and a twelve month high of $101.60. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. The stock has a market capitalization of $47.30 billion, a price-to-earnings ratio of 171.04, a P/E/G ratio of 1.95 and a beta of 0.69.

Ventas Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th were paid a dividend of $0.52 per share. The ex-dividend date was Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.3%. Ventas’s dividend payout ratio is currently 385.19%.

Insider Activity at Ventas

In other news, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the transaction, the director directly owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.53% of the company’s stock.

Hedge Funds Weigh In On Ventas

Hedge funds and other institutional investors have recently bought and sold shares of the business. Wiser Advisor Group LLC bought a new stake in Ventas in the third quarter valued at approximately $27,000. IFC & Insurance Marketing Inc. bought a new stake in Ventas in the 4th quarter valued at $30,000. Zions Bancorporation National Association UT raised its stake in Ventas by 250.3% in the 4th quarter. Zions Bancorporation National Association UT now owns 508 shares of the real estate investment trust’s stock valued at $39,000 after acquiring an additional 363 shares during the period. DV Equities LLC acquired a new stake in Ventas during the 4th quarter valued at $51,000. Finally, Rossby Financial LCC lifted its holdings in Ventas by 45.8% during the 4th quarter. Rossby Financial LCC now owns 729 shares of the real estate investment trust’s stock valued at $56,000 after purchasing an additional 229 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

About Ventas

(Get Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Featured Articles

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.